Literature DB >> 17950329

Steatocholecystitis: the influence of obesity and dietary carbohydrates.

Abhishek Mathur1, Hayder H Al-Azzawi, Debao Lu, Kyle W Yancey, Deborah A Swartz-Basile, Attila Nakeeb, Henry A Pitt.   

Abstract

INTRODUCTION: We have recently demonstrated that obese and lean mice fed a high fat diet have increased gallbladder wall fat and decreased gallbladder contractility, cholecystosteatosis. Animal and human data also suggest that diets high in refined carbohydrates lead to gallstone formation. However, no data are available on the role of dietary carbohydrates on gallbladder wall fat and inflammation. Therefore, we tested the hypothesis that both obesity and dietary carbohydrates would increase gallbladder fat and cytokines, steatocholecystitis.
METHODS: At 8 wk of age, 47 lean and 22 obese female mice were fed a 45% carbohydrate (CHO) diet while an equal number of lean and obese mice were fed a 75% CHO diet for 4 wk. All mice underwent cholecystectomy, and the gallbladders were snap-frozen. Individual and total lipids were measured by gas chromatography. Interleukin (IL)-1beta, tumor necrosis factor (TNF)-alpha, and IL-6 were measured by enzyme-linked immunosorbent assay. Data were analyzed by analysis of variance and Tukey test.
RESULTS: Gallbladder total fat, triglycerides, and cholesterol were maximum (P < 0.001) in obese mice on the 75% CHO diet. Gallbladder TNF-alpha and IL-1beta as well as serum cholesterol levels showed a similar pattern (P < 0.001). Gallbladder saturated free fatty acids and IL-6 levels were highest (P < 0.001) in obese mice on the 45% CHO diet.
CONCLUSIONS: These data suggest that (1) both obesity and dietary carbohydrates increase gallbladder total fat, triglycerides, cholesterol, TNF-alpha, and IL-1beta and (2) obesity also increases gallbladder free fatty acids and IL-6. Therefore, we conclude that obesity is associated with steatocholecystitis and that a high carbohydrate diet exacerbates this phenomenon.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950329      PMCID: PMC2431458          DOI: 10.1016/j.jss.2007.04.042

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  41 in total

1.  Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes.

Authors:  Kolapo M Ajuwon; Michel E Spurlock
Journal:  J Nutr       Date:  2005-08       Impact factor: 4.798

2.  Excess membrane cholesterol alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells.

Authors:  M M Gleason; M S Medow; T N Tulenko
Journal:  Circ Res       Date:  1991-07       Impact factor: 17.367

3.  MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder.

Authors:  Laetitia Finzi; Véronique Barbu; Pierre-Regis Burgel; Martine Mergey; Kimberly S Kirkwood; Elizabeth C Wick; Jean-Yves Scoazec; Frédérique Peschaud; François Paye; Jay A Nadel; Chantal Housset
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

4.  Decreased gallbladder response in leptin-deficient obese mice.

Authors:  Matthew I Goldblatt; Deborah A Swartz-Basile; Carol L Svatek; Atilla Nakeeb; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2002 May-Jun       Impact factor: 3.452

5.  Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity.

Authors:  Q Chen; J Amaral; P Biancani; J Behar
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

6.  TNFalpha suppresses human colonic circular smooth muscle cell contractility by SP1- and NF-kappaB-mediated induction of ICAM-1.

Authors:  Konrad Pazdrak; Xuan-Zheng Shi; Sushil K Sarna
Journal:  Gastroenterology       Date:  2004-10       Impact factor: 22.682

7.  Cholecystosteatosis: an explanation for increased cholecystectomy rates.

Authors:  Hayder H Al-Azzawi; Attila Nakeeb; Romil Saxena; Mary A Maluccio; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

8.  Circulating mononuclear cells in the obese are in a proinflammatory state.

Authors:  Husam Ghanim; Ahmad Aljada; Deborah Hofmeyer; Tufail Syed; Priya Mohanty; Paresh Dandona
Journal:  Circulation       Date:  2004-09-13       Impact factor: 29.690

9.  Ezetimibe ameliorates cholecystosteatosis.

Authors:  Abhishek Mathur; Julia J Walker; Hayder H Al-Azzawi; Debao Lu; Deborah A Swartz-Basile; Attila Nakeeb; Henry A Pitt
Journal:  Surgery       Date:  2007-08       Impact factor: 3.982

10.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

View more
  2 in total

1.  Nonalcoholic fatty pancreas disease.

Authors:  Abhishek Mathur; Megan Marine; Debao Lu; Deborah A Swartz-Basile; Romil Saxena; Nicholas J Zyromski; Henry A Pitt
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 2.  Steatocholecystitis and fatty gallbladder disease.

Authors:  Chung-Jyi Tsai
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.